Unlike the general anatomical abnormalities normally found in HCM patients, hearts from patients harboring cardiac troponin T (TNNT2) variants typically show significantly less ventricular hypertrophy compared to other HCM-associated variants. Here, TNNT2 is linked to cardiac hypertrophy.